GSE225375 CDK12 CDK13 inhibition 2 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE225375_CDK12_CDK13 inhibition_2_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE225375_CDK12_CDK13 inhibition_2_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE225375_CDK12_CDK13 inhibition_2_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE225375_CDK12_CDK13 inhibition_2_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

valyl-tRNA synthetase 1

Gene

mitochondrial ribosomal protein S18B

Gene

small nucleolar RNA host gene 4

Gene

OIP5 antisense RNA 1

Gene

small nucleolar RNA host gene 12

Gene

mitochondrial rRNA methyltransferase 1

Gene

VPS9D1 antisense RNA 1

Gene

small nucleolar RNA host gene 26

Gene

uncharacterized protein MGC12916

Gene

DEPDC1 antisense RNA 1

  • Gene

    valyl-tRNA synthetase 1


  • Gene

    mitochondrial ribosomal protein S18B


  • Gene

    small nucleolar RNA host gene 4


  • Gene

    OIP5 antisense RNA 1


  • Gene

    small nucleolar RNA host gene 12


  • Gene

    mitochondrial rRNA methyltransferase 1


  • Gene

    VPS9D1 antisense RNA 1


  • Gene

    small nucleolar RNA host gene 26


  • Gene

    uncharacterized protein MGC12916


  • Gene

    DEPDC1 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.